Securities code: 600998 securities abbreviation: Jointown Pharmaceutical Group Co.Ltd(600998) Announcement No.: pro 2022-006 convertible bond Code: 110034 convertible bond abbreviation: Kyushu convertible bond
Jointown Pharmaceutical Group Co.Ltd(600998)
Announcement on due payment and delisting of “Kyushu convertible bonds”
The company and all members of the board of directors guarantee that there are no false records, misleading statements or major omissions in the contents of the announcement, and bear individual and joint liabilities for the authenticity, accuracy and completeness of the contents. Important content tips:
Maturity date and payment registration date of convertible bonds: Friday, January 14, 2022
Cashing amount of principal and interest: 108 yuan / piece (including tax)
Payment date: January 17, 2022 (Monday)
Delisting date of convertible bonds: January 17, 2022 (Monday)
Jointown Pharmaceutical Group Co.Ltd(600998) (hereinafter referred to as “the company” or “the company”) approved by CSRC zjxk [2016] No. 11, issued 15 million convertible corporate bonds (hereinafter referred to as “convertible bonds”) to the public through Shanghai Stock Exchange on January 15, 2016, with a term of 6 years (i.e. from January 15, 2016 to January 14, 2022), It has been listed and traded in Shanghai Stock Exchange since January 29, 2016. The securities are referred to as “Kyushu convertible bonds” for short, and the securities code is “110034”. Kyushu convertible bonds have entered the conversion period since July 21, 2016 and will expire on January 14, 2022.
In accordance with the provisions of the measures for the administration of securities issuance of listed companies, the stock listing rules of Shanghai Stock Exchange and the company’s prospectus for public issuance of convertible corporate bonds (hereinafter referred to as the prospectus), the matters related to the due cashing and delisting of the company’s “Kyushu convertible bonds” are hereby announced as follows:
1、 Cashing scheme
According to the provisions of the company’s prospectus: within five trading days after the maturity of the convertible bonds issued this time, the company will redeem all the convertible bonds that have not been converted to shares from investors at the price of 108% of the face value of the bonds (including the last interest). Therefore, the due cashing amount of “Kyushu convertible bonds” is 108 yuan / piece (including tax).
2、 Registration date of convertible bond cashing
The due date of “Kyushu convertible bonds” and the registration date of creditor’s rights due for payment are January 14, 2022. The due payment objects are all the holders of “Kyushu convertible bonds” registered in Shanghai Branch of China Securities Depository and Clearing Co., Ltd. after the closing of Shanghai Stock Exchange on January 14, 2022.
3、 Due cashing amount and fund release date
The due cashing amount of “Kyushu convertible bonds” is 108.00 yuan / piece (including tax), and the fund issuance date is January 17, 2022.
4、 Cashing method
The principal and last year’s interest of “Kyushu convertible bonds” will be transferred to the capital account of relevant holders of “Kyushu convertible bonds” by China Securities Depository and Clearing Co., Ltd. Shanghai branch through the custody broker.
5、 Delisting date of convertible bonds
The delisting date of “Kyushu convertible bonds” (Code: 110034) is January 17, 2022. Since December 31, 2021, “Kyushu convertible bonds” have stopped trading. From January 17, 2022, “Kyushu convertible bonds” will stop converting shares and delisted in Shanghai Stock Exchange.
6、 Notes on interest income tax of convertible corporate bonds
According to the individual income tax law of the people’s Republic of China and other relevant tax laws, regulations and documents, individual investors of the company’s convertible bonds shall perform their tax obligations. According to the relevant provisions of the company’s prospectus, the company will redeem the convertible bonds not converted into shares at the price of 108% of the face value of the bonds (including the face interest rate of the last year of 2%), in which the income tax on the interest part will be uniformly withheld and paid by each cashing institution at the tax rate of 20%, that is, the actual distribution amount of each convertible bond with a face value of RMB 100 is RMB 107.6 (after tax). If the obligation of withholding and payment is not fulfilled, the legal liability arising therefrom shall be borne by each cashing institution.
According to the provisions of the enterprise income tax law of the people’s Republic of China and other relevant tax laws, regulations and documents, for resident enterprises holding convertible bonds, the bond interest income tax shall be paid by themselves, that is, the actual distribution amount of each convertible bond with a face value of 100 yuan is 108.00 yuan (including tax).
For non resident enterprises such as qualified foreign institutional investors (QFII) and RMB foreign institutional investors (hereinafter referred to as “QFII” and “rqfii”) holding convertible bonds (the meaning is the same as the enterprise income tax law of the people’s Republic of China), According to the announcement on the continuation of the enterprise income tax and value-added tax policies for overseas institutions\’ investment in the domestic bond market (Announcement No. 34, 2021 of the State Administration of Taxation of the Ministry of Finance), the bond interest income obtained by overseas institutions\’ investment in the domestic bond market will be temporarily exempted from enterprise income tax and value-added tax from November 7, 2021 to December 31, 2025, That is, the actual distribution amount of each convertible bond with a face value of 100 yuan is 108.00 yuan (including tax). The scope of the above temporary exemption from enterprise income tax does not include the bond interest actually connected with the institutions and sites established by overseas institutions in China.
Other investors holding convertible bonds shall perform corresponding tax obligations in accordance with the provisions of relevant tax regulations and documents.
7、 Other
Issuer: Jointown Pharmaceutical Group Co.Ltd(600998)
Contact Department: Secretariat of the board of directors
Tel.: 027-84683017
Contact address: No. 8, Longyang Avenue, Hanyang District, Wuhan City, Hubei Province
It is hereby announced.
Jointown Pharmaceutical Group Co.Ltd(600998) board of directors January 12, 2022
